Daily Bulletin

Men's Weekly

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

What Businesses Need to Know About Intellectual Property Law

Whether you're launching a startup or growing an established brand, understanding intellectual property law is essential. An intellectual property lawyer in Melbourne can guide you through registrat...

Daily Bulletin - avatar Daily Bulletin

Avoiding the Delays – Why Families Hire Registered Migration Agents for Their Parent Visa Application

For many migrants, bringing in their ageing parents to reside with them in Australia is one of the most significant milestones. However, the visa pathway is not always simple. The daunting prerequisit...

Daily Bulletin - avatar Daily Bulletin

The ultimate checklist for launching a digital-first business

If you’re launching a business in 2025, chances are it’s going to be digital-first. Whether you’re running an online store, offering consulting services, or building something entirely new, they all h...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals